Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease — Stella

Home/Tuberculosis (TB)/A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

View on ClinicalTrials.gov

Recruiting

Back to Tuberculosis (TB) trials

A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

The Gambia

MRC Unit The Gambia at LSHTM, Fajara, The Gambia

Key details

Sponsor

The Aurum Institute NPC

Collaborators

Ludwig-Maximilians - University of Munich, Research Center Borstel

Enrollment target

~242 participants

Started

April 2025

Primary completion

December 2027

Age range

18 Years – 65 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.